Group 1 - The company has received a notification from the National Medical Products Administration regarding the approval of a supplementary application for the drug Acyclovir Hydrochloride Tablets, indicating that it has passed the consistency evaluation of quality and efficacy for generic drugs [1][3] - The drug is classified as a chemical drug and is available in a 0.5g tablet form, packaged in bottles of 30 tablets [1] - The approval is expected to enhance the company's market competitiveness in the pharmaceutical sector and positively impact future operating performance [3] Group 2 - The drug is indicated for the treatment of shingles, herpes simplex virus infections, and for the prevention of recurrent herpes simplex virus infections [2] - The approval of the drug's new specification is anticipated to better meet market demand [3]
珠海润都制药股份有限公司 关于盐酸伐昔洛韦片获得药品补充申请批准通知书的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-09-25 23:55